Rift Valley Fever: The Mosquito-Borne Zoonosis That Wiped Out Livestock and Crossed Into Arabia
Key Facts
- First identified in 1931 during a sheep epidemic on a farm in the Rift Valley of Kenya — yet it remains without a licensed human vaccine nearly a century later.
- Incubation period of 2 to 6 days, with mild-case symptoms lasting just 4 to 7 days, making early clinical detection a persistent challenge.
- Less than 1% overall case fatality rate — but among patients who develop the haemorrhagic fever form, the fatality ratio climbs to approximately 50%.
- 0.5–2% of patients develop the ocular (eye) form; when lesions appear in the macula, WHO reports that 50% of those patients experience permanent vision loss.
- No human-to-human transmission of RVF has ever been documented — yet the virus reached Saudi Arabia and Yemen in 2000, marking its first confirmed presence outside the African continent.
In January 2024, WHO spotlighted the Afrique One collaboration-building initiative, aimed at strengthening scientific capacity in Africa who — a quiet signal that Rift Valley fever, while not dominating global headlines the way Ebola or mpox does, remains firmly on WHO’s radar. And for good reason. hen the right combination of rainfall, flooding, and livestock movement occurs, RVF can erupt fast, devastate animal populations, and then spill into human communities with little warning.
This article reports what WHO documents about Rift Valley fever — its transmission, symptoms, global footprint, and the public health architecture being built to contain it. Explore more health news and analysis here.
What Is Rift Valley Fever? — WHO’s Definition
According to WHO, Rift Valley fever is a viral zoonosis that primarily affects animals but can also infect humans, with the capacity to cause severe disease in both. The virus belongs to the Phlebovirus genus and was first identified in 1931 during an investigation into an epidemic among sheep in Kenya’s Rift Valley. who
WHO’s documentation traces the disease’s spread methodically across the decades. In 1977, an explosive outbreak struck Egypt, where the RVF virus was introduced via infected livestock trade along the Nile irrigation system. In 1997–98, a major outbreak occurred in Kenya, Somalia, and Tanzania following an El Niño event and extensive flooding. who The year 2000 marked a geographic turning point. Following infected livestock trade from the Horn of Africa, RVF spread to Saudi Arabia and Yemen in September 2000 — the first reported occurrence of the disease outside the African continent — raising concerns it could extend to other parts of Asia and Europe. who
Global Burden
WHO’s geographic scope for RVF is specific: outbreaks have historically struck sub-Saharan Africa and North Africa, with the 2000 Arabian Peninsula episode representing its only confirmed jump beyond Africa.
The disease results in significant economic losses due to death and abortion among RVF-infected livestock. who An outbreak frequently announces itself as a cluster of unexplained animal abortions before human cases even appear — a grim early-warning signal that public health authorities have learned to watch for.
The disease is not evenly distributed among human populations. Certain occupational groups — herders, farmers, slaughterhouse workers, and veterinarians — are at higher risk of infection who because their livelihoods bring them into direct, repeated contact with animals. These groups often work in regions with the fewest diagnostic resources. Is the gap in occupational health protections for rural agricultural workers in affected regions receiving enough attention? The data suggests it isn’t.
Causes, Transmission & Risk Factors
Most human infections result from direct or indirect contact with the blood or organs of infected animals — through handling of animal tissue during slaughtering or butchering, assisting with animal births, conducting veterinary procedures, or from the disposal of carcasses or fetuses. who
There is some evidence that humans may become infected with RVF by ingesting the unpasteurized or uncooked milk of infected animals. who
Mosquito bites represent a second pathway. Human infections have also resulted from the bites of infected mosquitoes, most commonly Aedes and Culex mosquitoes. The transmission of RVF virus by blood-feeding flies is also possible. who
The ecology is notable. The female Aedes mosquito is capable of transmitting the virus directly to her offspring via eggs, leading to new generations of infected mosquitoes hatching. who This vertical transmission mechanism helps explain how the virus can persist quietly between major outbreaks, biding time until climatic conditions create an opportunity.
Irrigation schemes, where populations of mosquitoes are abundant during long periods of the year, are highly favourable places for secondary disease transmission. who The 1977 Egypt outbreak along the Nile irrigation system illustrated this dynamic precisely. When the infrastructure that feeds crops also sustains vector populations year-round, the risk calculus shifts dramatically.
Signs, Symptoms & Health Impacts
WHO identifies a disease that looks very different depending on which patient is in front of you.
Most infections in humans lead to no symptoms or a mild form of the disease characterized by a feverish syndrome with sudden onset of flu-like fever, muscle and joint pain, and headache. Some patients develop neck stiffness, sensitivity to light, loss of appetite, and vomiting. In these patients the disease, in its early stages, may be mistaken for meningitis. who
The symptoms of RVF usually last from 4 to 7 days, after which the immune response becomes detectable with the appearance of antibodies and the virus disappears from the blood. who
But a small percentage of patients develop something far more serious. WHO documents three distinct severe syndromes:
Ocular (eye) form (0.5–2% of patients): Retinal lesions typically appear 1 to 3 weeks after the first symptoms. Patients report blurred or decreased vision. When the lesions occur in the macula, 50% of patients will experience a permanent loss of vision. who
Meningoencephalitis form (less than 1% of patients): Onset usually occurs 1 to 4 weeks after the first symptoms and includes intense headache, loss of memory, hallucinations, confusion, disorientation, vertigo, convulsions, lethargy, and coma. While death rate in these patients is low, residual neurological deficit, which may be severe, is common. who
Haemorrhagic fever form (less than 1% of patients): Symptoms appear 2 to 4 days after onset of illness, beginning with evidence of severe liver impairment. Signs of haemorrhage then follow — vomiting blood, passing blood in the faeces, a purpuric rash, bleeding from the nose or gums, and bleeding from venepuncture sites. The case fatality ratio in these patients is high at approximately 50%, with death usually occurring 3 to 6 days after the onset of symptoms. who
Treatment & Health Response
As most human cases of RVF are relatively mild and of short duration, no specific treatment is required. For the more severe cases, the predominant treatment is early intensive supportive care including fluid management and treatment of specific symptoms. who
On vaccines: an inactivated vaccine has been developed for human use, but this vaccine is not licensed and is not commercially available. It has been used experimentally to protect veterinary and laboratory personnel at high risk of exposure to RVF. Other candidate vaccines are under investigation. who That’s a significant unresolved gap — a disease that has already demonstrated it can jump continents via livestock trade still lacks a deployable licensed human vaccine.
Because RVF is difficult to distinguish clinically from other viral haemorrhagic fevers as well as from malaria and typhoid fever, definitive diagnosis requires laboratory testing — including RT-PCR assays, IgG and IgM antibody ELISA, and virus isolation by cell culture. who WHO emphasizes that samples from suspected patients pose extreme biohazard risk and must be handled under maximum biological containment conditions.
Prevention & WHO Strategies
WHO’s prevention framework operates on multiple tracks.
Outbreaks of RVF in animals can be prevented by a sustained programme of preventive animal vaccination. who One critical constraint WHO highlights: once an outbreak has occurred, animal vaccination should NOT be implemented because there is a high risk of intensifying the outbreak through the use of multi-dose vials and the re-use of needles and syringes. who The vaccination window is before an outbreak, not during it. Timing is everything.
Restricting or banning the movement of livestock may be effective in slowing the expansion of the virus from infected to uninfected areas. who
For humans, WHO’s public health messaging covers reducing animal-to-human risk through hand hygiene and protective equipment when handling sick animals; avoiding raw blood, uncooked meat, and unpasteurized milk in affected regions; protecting against mosquito bites using impregnated nets, personal insect repellent, light-coloured long-sleeved clothing, and by avoiding outdoor activity at peak mosquito biting hours; and vector control through larviciding at identifiable breeding sites.
No transmission of RVF to health care workers has been reported when standard infection control precautions have been implemented. who
WHO’s Global Efforts
WHO is working with partners to support RVF surveillance, diagnostic capacity, patient care, and outbreak response activities in at-risk countries. WHO coordinates with the Food and Agriculture Organization of the United Nations (FAO) and the World Organization of Animal Health (WOAH) to improve anticipation of outbreaks in humans and implement activities at the animal-human-ecosystem interface. who
This tripartite structure reflects the One Health principle — acknowledging that RVF simply can’t be managed by human health authorities alone because the disease originates in animals and moves through ecological systems shaped by climate.
In Africa, Saudi Arabia, and Yemen, RVF outbreaks are closely associated with periods of above-average rainfall. In East Africa they are closely associated with the heavy rainfall that occurs during the warm phase of the El Niño–Southern Oscillation phenomenon. Forecasting models and early warning systems using satellite images and weather/climate forecasting data can trigger detection of animal cases at an early stage, enabling authorities to implement measures to avert epidemics. who
From an editorial standpoint, this forecasting investment is arguably the most strategically important work WHO is doing on RVF right now. A vaccine gap that persists for nearly a century won’t be closed quickly. But an early-warning system that gives veterinary and public health authorities days or weeks of lead time is achievable with existing technology. The 1997–98 East Africa outbreak demonstrated what happens when warning signs are missed. The forecasting models built in its aftermath may be that epidemic’s most consequential legacy.
Is it enough? With RVF having crossed into Arabia once via livestock trade, stronger international biosecurity standards for livestock movement — particularly from the Horn of Africa — deserves more prominence in the global response architecture than WHO’s current published framework explicitly addresses.
Related Articles
- Lassa Fever: Acute Viral Haemorrhagic Illness Caused by Lassa Virus
- Ebola Virus Disease: The Deadly Hemorrhagic Fever We’re Learning to Fight
- Crimean-Congo Hemorrhagic Fever: Why This Deadly Tick-Borne Virus Kills 30% of Victims
- Respiratory Syncytial Virus: The Common Infection Hospitalizing Millions of Babies
- Pneumonia: The Infectious Lung Disease Killing 740,000 Children Yearly
- World Sickle Cell Awareness Day and Its Significance
- Explore World History
Frequently Asked Questions
According to WHO, Rift Valley fever is a viral zoonosis caused by a Phlebovirus that primarily affects animals but can infect humans. Most human cases result from direct contact with blood or organs of infected animals during handling or slaughter. Infection via mosquito bites — primarily Aedes and Culex species — is also documented. No human-to-human transmission has ever been recorded.
WHO identifies a spectrum of disease. Mild cases — the majority — present as flu-like illness with sudden fever, muscle and joint pain, and headache, typically resolving in 4 to 7 days. A small percentage develop severe forms: ocular disease with potential permanent vision loss (0.5–2%), meningoencephalitis (less than 1%), or haemorrhagic fever (less than 1%), which carries a case fatality ratio of approximately 50%.
WHO reports that an inactivated human vaccine has been developed but is not licensed or commercially available. It has only been used experimentally for high-risk veterinary and laboratory workers. For mild cases, no specific treatment is needed. Severe cases receive intensive supportive care. Animal vaccines exist for veterinary use and are WHO’s primary outbreak prevention tool.
WHO documents that RVF has historically affected sub-Saharan Africa and North Africa. The disease spread to Saudi Arabia and Yemen in 2000 via infected livestock trade — its only confirmed occurrence outside Africa. Outbreaks are closely associated with heavy rainfall and flooding, particularly El Niño events in East Africa, and with regions relying on irrigation schemes that sustain large mosquito populations year-round.
WHO identifies herders, farmers, slaughterhouse workers, and veterinarians as the highest-risk groups due to repeated direct contact with animal blood, organs, and tissues. Individuals consuming unpasteurized or raw milk from infected animals also face elevated risk. People living near large mosquito populations during rainy seasons in affected regions carry additional exposure risk.
Sources
- World Health Organization. Rift Valley Fever — Health Topic. https://www.who.int/health-topics/rift-valley-fever
- World Health Organization. Rift Valley Fever — Fact Sheet (Updated December 20, 2024). https://www.who.int/news-room/fact-sheets/detail/rift-valley-fever
- Centers for Disease Control and Prevention. Rift Valley Fever. https://www.cdc.gov/rift-valley-fever
- Food and Agriculture Organization of the United Nations. Rift Valley Fever. https://www.fao.org/
This article adapts publicly available information from WHO’s Rift Valley Fever page. This content is for informational and educational purposes only and does not constitute medical advice. ObserverVoice.com is a news and information platform — not a healthcare provider.
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
